002252 上海莱士
已收盘 07-11 15:00:00
资讯
新帖
简况
上海莱士:SR604注射液进入Ⅱb期临床试验研究
格隆汇 · 07-08
上海莱士:SR604注射液进入Ⅱb期临床试验研究
上海莱士(002252.SZ):SR604注射液进入Ⅱb期临床试验研究
智通财经 · 07-08
上海莱士(002252.SZ):SR604注射液进入Ⅱb期临床试验研究
生物制品行业盘中跳水,上海莱士平盘
市场透视 · 07-07
生物制品行业盘中跳水,上海莱士平盘
上海莱士:南岳生物完成工商变更登记
证券之星 · 07-04
上海莱士:南岳生物完成工商变更登记
上海莱士:截至2025年6月30日股东总户数为100,031户
证券之星 · 07-04
上海莱士:截至2025年6月30日股东总户数为100,031户
上海莱士:累计回购公司股份50973052股
证券日报网 · 07-01
上海莱士:累计回购公司股份50973052股
上海莱士6月25日现2笔大宗交易 总成交金额4.68亿元 溢价率为-0.44%
新浪证券-红岸工作室 · 06-25
上海莱士6月25日现2笔大宗交易 总成交金额4.68亿元 溢价率为-0.44%
上海莱士:截至2025年6月20日股东总户数为101,480户
证券之星 · 06-25
上海莱士:截至2025年6月20日股东总户数为101,480户
6月20日上海莱士发布公告,股东增持1402.76万股
证券之星 · 06-20
6月20日上海莱士发布公告,股东增持1402.76万股
每周股票复盘:上海莱士(002252)股东户数增加,推进南岳生物股权收购
证券之星 · 06-13
每周股票复盘:上海莱士(002252)股东户数增加,推进南岳生物股权收购
上海莱士6月13日现2笔大宗交易 总成交金额548.44万元 其中机构买入548.44万元 溢价率为0.00%
新浪证券-红岸工作室 · 06-13
上海莱士6月13日现2笔大宗交易 总成交金额548.44万元 其中机构买入548.44万元 溢价率为0.00%
上海莱士:公司董事长的任职符合《公司法》《上市公司治理准则》等相关规定
证券之星 · 06-12
上海莱士:公司董事长的任职符合《公司法》《上市公司治理准则》等相关规定
上海莱士(002252)5月30日股东户数10.65万户,较上期增加1.02%
证券之星 · 06-09
上海莱士(002252)5月30日股东户数10.65万户,较上期增加1.02%
每周股票复盘:上海莱士(002252)累计回购股份46,729,752股
证券之星 · 06-07
每周股票复盘:上海莱士(002252)累计回购股份46,729,752股
中证上海现代产业发展主题指数报1167.68点,前十大权重包含上海莱士等
金融界 · 06-05
中证上海现代产业发展主题指数报1167.68点,前十大权重包含上海莱士等
上海莱士:目前,公司暂未有相关计划;若有相关事项,公司将按照信息披露相关规则履行披露义务
证券之星 · 05-29
上海莱士:目前,公司暂未有相关计划;若有相关事项,公司将按照信息披露相关规则履行披露义务
上海莱士:公司高管薪酬方案由董事会薪酬与考核委员会制定
证券之星 · 05-29
上海莱士:公司高管薪酬方案由董事会薪酬与考核委员会制定
每周股票复盘:上海莱士(002252)股东户数减少,控股股东计划增持25000万至50000万
证券之星 · 05-24
每周股票复盘:上海莱士(002252)股东户数减少,控股股东计划增持25000万至50000万
上海莱士:上市公司股价受市场、政策等多重因素影响
证券之星 · 05-23
上海莱士:上市公司股价受市场、政策等多重因素影响
上海莱士(002252)5月20日股东户数10.54万户,较上期减少0.65%
证券之星 · 05-23
上海莱士(002252)5月20日股东户数10.54万户,较上期减少0.65%
加载更多
公司概况
公司名称:
上海莱士血液制品股份有限公司
所属行业:
医药制造业
上市日期:
2008-06-23
主营业务:
上海莱士血液制品股份有限公司的主营业务是血液制品的生产和销售。公司的主要产品是自产白蛋白、进口白蛋白、静丙、其他血液制品、检测设备及试剂。公司是“上海市外商投资先进技术企业”、“高新技术企业”。
发行价格:
12.81
{"stockData":{"symbol":"002252","market":"SZ","secType":"STK","nameCN":"上海莱士","latestPrice":6.92,"timestamp":1752217392000,"preClose":6.94,"halted":0,"volume":45412600,"delay":0,"changeRate":-0.0029,"floatShares":6634000000,"shares":6638000000,"eps":0.3017,"marketStatus":"已收盘","change":-0.02,"latestTime":"07-11 15:00:00","open":6.95,"high":6.96,"low":6.91,"amount":315000000,"amplitude":0.0072,"askPrice":6.93,"askSize":1526,"bidPrice":6.92,"bidSize":5012,"shortable":0,"etf":0,"ttmEps":0.3017,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1752456600000},"marketStatusCode":5,"adr":0,"adjPreClose":6.94,"symbolType":"stock","openAndCloseTimeList":[[1752197400000,1752204600000],[1752210000000,1752217200000]],"highLimit":7.63,"lowLimit":6.25,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":6637984837,"isCdr":false,"pbRate":1.42,"roa":"--","peRate":22.936692,"roe":"1.76%","epsLYR":0.33,"committee":-0.074786,"marketValue":45935000000,"turnoverRate":0.0068,"status":1,"nextConnectDate":"根据港交所公布的数据,今日已停止北向交易,下一个交易日为北京时间 2025-07-14。","floatMarketCap":45911000000},"requestUrl":"/m/hq/s/002252","defaultTab":"news","newsList":[{"id":"2549458095","title":"上海莱士:SR604注射液进入Ⅱb期临床试验研究","url":"https://stock-news.laohu8.com/highlight/detail?id=2549458095","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549458095?lang=zh_cn&edition=full","pubTime":"2025-07-08 18:09","pubTimestamp":1751969396,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK1576","BK0196","BK1141","BK0028","BK0046","03347","BK0188","BK0239","BK1583","002252"],"gpt_icon":0},{"id":"2549545314","title":"上海莱士(002252.SZ):SR604注射液进入Ⅱb期临床试验研究","url":"https://stock-news.laohu8.com/highlight/detail?id=2549545314","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549545314?lang=zh_cn&edition=full","pubTime":"2025-07-08 18:07","pubTimestamp":1751969270,"startTime":"0","endTime":"0","summary":"智通财经APP讯,上海莱士 公告,公司近日在国家药品监督管理局药物临床试验登记与信息公示平台公示了IIb期临床试验登记信息,试验名称为:评价SR604注射液在血友病A/B及先天性凝血因子Ⅶ缺乏症患者中的安全性、耐受性、有效性、PK/PD特征的开放、多中心Ⅰ/Ⅱ期临床试验。据公告所示,SR604注射液拟用于血友病A/B及先天性凝血因子Ⅶ缺乏症患者出血的预防治疗。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1315245.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["002252","BK0188","BK1576","BK0196","BK1583","BK0028","03347","BK0239","BK1141","BK0046"],"gpt_icon":0},{"id":"2549158321","title":"生物制品行业盘中跳水,上海莱士平盘","url":"https://stock-news.laohu8.com/highlight/detail?id=2549158321","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549158321?lang=zh_cn&edition=full","pubTime":"2025-07-07 14:31","pubTimestamp":1751869907,"startTime":"0","endTime":"0","summary":"07月07日,生物制品行业盘中跳水,截至14点31分,生物制品行业整体指数下跌2.01%,报6225.840点。从个股上来看,该行业的成分股中,上海莱士平盘,跌幅居前。从资金上来看,截止发稿,生物制品行业主力净流入为-7.50亿,其中天坛生物受到资金热捧,主力净流入5273.73万;拉长时间线来看,该板块近20日主力资金净流入-27.10亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707143147a69a4d38&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707143147a69a4d38&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["002252","BK0046","BK0188","600161","BK0082","BK0196","BK0010","BK0028","BK0239","BK0168","BK0185"],"gpt_icon":0},{"id":"2548736506","title":"上海莱士:南岳生物完成工商变更登记","url":"https://stock-news.laohu8.com/highlight/detail?id=2548736506","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548736506?lang=zh_cn&edition=full","pubTime":"2025-07-04 16:30","pubTimestamp":1751617841,"startTime":"0","endTime":"0","summary":"2025年6月20日,公司披露了《关于收购南岳生物制药有限公司100%股权进展暨完成工商变更登记的公告》,南岳生物完成了相关工商变更登记手续,同时完成董事、监事、高级管理人员选任及相关的工商备案手续。上述变更登记手续完成后,公司持有南岳生物100% 股权,南岳生物成为公司全资子公司。关于广西莱士进展,目前,广西莱士正处于试生产阶段。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025070400025709.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0196","BK0188","BK0028","002252","BK0239"],"gpt_icon":0},{"id":"2548339337","title":"上海莱士:截至2025年6月30日股东总户数为100,031户","url":"https://stock-news.laohu8.com/highlight/detail?id=2548339337","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548339337?lang=zh_cn&edition=full","pubTime":"2025-07-04 08:42","pubTimestamp":1751589736,"startTime":"0","endTime":"0","summary":"证券之星消息,上海莱士(002252)07月03日在投资者关系平台上答复投资者关心的问题。投资者提问:请问截止6月30日,公司的股东总户数是多少?谢谢。上海莱士回复:您好!感谢您对我公司的关心和支持! 截至2025年6月30日,公司股东总户数为100,031户。 谢谢。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025070400006218.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0196","BK0046","BK0239","002252","BK0188"],"gpt_icon":0},{"id":"2548300020","title":"上海莱士:累计回购公司股份50973052股","url":"https://stock-news.laohu8.com/highlight/detail?id=2548300020","media":"证券日报网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548300020?lang=zh_cn&edition=full","pubTime":"2025-07-01 22:10","pubTimestamp":1751379000,"startTime":"0","endTime":"0","summary":"证券日报网讯7月1日晚间,上海莱士发布公告称,截至2025年6月30日,公司通过股份回购专用证券账户以集中竞价方式累计回购公司股份50,973,052股,占公司总股本的0.77%。\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2025-07-01/doc-infcytwy8632258.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-07-01/doc-infcytwy8632258.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0046","BK0188","BK0196","BK0028","BK0239","002252"],"gpt_icon":0},{"id":"2546929087","title":"上海莱士6月25日现2笔大宗交易 总成交金额4.68亿元 溢价率为-0.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2546929087","media":"新浪证券-红岸工作室","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546929087?lang=zh_cn&edition=full","pubTime":"2025-06-25 17:00","pubTimestamp":1750842000,"startTime":"0","endTime":"0","summary":" 6月25日,上海莱士收涨0.29%,收盘价为6.89元,发生2笔大宗交易,合计成交量6817.66万股,成交金额4.68亿元。 第1笔成交价格为6.86元,成交2,396.99万股,成交金额16,443.35万元,溢价率为-0.44%,买方营业部为中信建投证券股份有限公司北京商务中心区机构专用证券营业部,卖方营业部为机构专用。 进一步统计,近3个月内该股累计发生4笔大宗交易,合计成交金额为4.73亿元。该股近5个交易日累计上涨1.03%,主力资金合计净流出5603.32万元。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/ggzz/2025-06-25/doc-infchqmk5699201.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0239","BK0028","BK0188","BK0046","002252","BK0196"],"gpt_icon":0},{"id":"2546229271","title":"上海莱士:截至2025年6月20日股东总户数为101,480户","url":"https://stock-news.laohu8.com/highlight/detail?id=2546229271","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546229271?lang=zh_cn&edition=full","pubTime":"2025-06-25 16:54","pubTimestamp":1750841658,"startTime":"0","endTime":"0","summary":"证券之星消息,上海莱士(002252)06月25日在投资者关系平台上答复投资者关心的问题。投资者提问:请问公司最近一期的股东人数是多少?谢谢上海莱士回复:您好!感谢您对我公司的关心和支持! 截至2025年6月20日,公司股东总户数为101,480户。 谢谢。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025062500026837.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0028","002252","BK0196","BK0188","BK0046"],"gpt_icon":0},{"id":"2544292211","title":"6月20日上海莱士发布公告,股东增持1402.76万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2544292211","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544292211?lang=zh_cn&edition=full","pubTime":"2025-06-20 19:01","pubTimestamp":1750417305,"startTime":"0","endTime":"0","summary":"证券之星消息,6月20日上海莱士发布公告《上海莱士:关于控股股东增持公司股份进展暨权益变动触及1%的公告》,其股东海盈康(青岛)医疗科技有限公司于2025年5月22日至2025年6月19日间合计增持1402.76万股,占公司目前总股本的0.2113%,变动期间该股股价上涨0.15%,截止6月19日收盘报6.81元。股东增减持详情见下表:根据上海莱士2025年一季报公布的十大股东详情如下:以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025062000031090.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002252","BK0188","BK0028","BK0046","BK0196","BK0239"],"gpt_icon":0},{"id":"2543558986","title":"每周股票复盘:上海莱士(002252)股东户数增加,推进南岳生物股权收购","url":"https://stock-news.laohu8.com/highlight/detail?id=2543558986","media":"证券之星","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543558986?lang=zh_cn&edition=full","pubTime":"2025-06-14 06:37","pubTimestamp":1749854230,"startTime":"0","endTime":"0","summary":"截至2025年6月13日收盘,上海莱士报收于6.89元,较上周的7.0元下跌1.57%。本周,上海莱士6月10日盘中最高价报7.04元。股本股东变化近日上海莱士披露,截至2025年5月30日公司股东户数为10.65万户,较5月20日增加1080户,增幅为1.02%。公司公告汇总上海莱士血液制品股份有限公司与多方签署协议,收购南岳生物制药有限公司100%股权。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025061400009609.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0188","BK0239","002252","BK0196","BK0028"],"gpt_icon":0},{"id":"2543504603","title":"上海莱士6月13日现2笔大宗交易 总成交金额548.44万元 其中机构买入548.44万元 溢价率为0.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2543504603","media":"新浪证券-红岸工作室","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543504603?lang=zh_cn&edition=full","pubTime":"2025-06-13 17:00","pubTimestamp":1749805200,"startTime":"0","endTime":"0","summary":" 6月13日,上海莱士收跌0.86%,收盘价为6.89元,发生2笔大宗交易,合计成交量79.6万股,成交金额548.44万元。 第1笔成交价格为6.89元,成交33.00万股,成交金额227.37万元,溢价率为0.00%,买方营业部为机构专用,卖方营业部为机构专用。 进一步统计,近3个月内该股累计发生2笔大宗交易,合计成交金额为548.44万元。该股近5个交易日累计下跌1.57%,主力资金合计净流出3238.74万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/ggzz/2025-06-13/doc-inezxpfh6442072.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0188","BK0028","BK0239","BK0196","002252","BK0046"],"gpt_icon":0},{"id":"2542551879","title":"上海莱士:公司董事长的任职符合《公司法》《上市公司治理准则》等相关规定","url":"https://stock-news.laohu8.com/highlight/detail?id=2542551879","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542551879?lang=zh_cn&edition=full","pubTime":"2025-06-12 08:57","pubTimestamp":1749689828,"startTime":"0","endTime":"0","summary":"证券之星消息,上海莱士(002252)06月12日在投资者关系平台上答复投资者关心的问题。投资者提问:请问董事长谭丽霞任职三家不同性质的上市公司董事长且经营地不在同一城市,是怎么做到尽职的?是不是侧面也反应海尔高级管理人才短缺?上海莱士回复:您好!感谢您对我公司的关心和支持!公司董事长的任职符合《公司法》《上市公司治理准则》等相关规定,任职期间勤勉尽责,通过合理安排时间参与相关公司的各项工作。谢谢。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025061200004076.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0028","BK0239","BK0196","002252","BK0046"],"gpt_icon":0},{"id":"2542802530","title":"上海莱士(002252)5月30日股东户数10.65万户,较上期增加1.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2542802530","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542802530?lang=zh_cn&edition=full","pubTime":"2025-06-09 17:13","pubTimestamp":1749460424,"startTime":"0","endTime":"0","summary":"证券之星消息,近日上海莱士披露,截至2025年5月30日公司股东户数为10.65万户,较5月20日增加1080.0户,增幅为1.02%。在生物制品行业个股中,上海莱士股东户数高于行业平均水平,截至5月30日,生物制品行业平均股东户数为3.39万户。从股价来看,2025年5月20日至2025年5月30日,上海莱士区间涨幅为0.29%,在此期间股东户数增加1080.0户,增幅为1.02%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025060900021811.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0196","BK0028","BK0188","002252","BK0239","BK0046"],"gpt_icon":0},{"id":"2541978148","title":"每周股票复盘:上海莱士(002252)累计回购股份46,729,752股","url":"https://stock-news.laohu8.com/highlight/detail?id=2541978148","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2541978148?lang=zh_cn&edition=full","pubTime":"2025-06-07 10:23","pubTimestamp":1749262987,"startTime":"0","endTime":"0","summary":"截至2025年6月6日收盘,上海莱士报收于7.0元,较上周的6.81元上涨2.79%。本周,上海莱士6月4日盘中最高价报7.04元。本周关注点公司公告汇总:截至2025年5月30日,上海莱士累计回购股份46,729,752股,成交总金额为319,560,846.98元公司公告汇总截至2025年5月30日,上海莱士血液制品股份有限公司累计回购股份46,729,752股,占公司总股本的0.70%,最高成交价为7.09元/股,最低成交价为6.62元/股,成交总金额为319,560,846.98元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025060700010005.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0196","BK0046","BK0239","002252","BK0188"],"gpt_icon":0},{"id":"2541282440","title":"中证上海现代产业发展主题指数报1167.68点,前十大权重包含上海莱士等","url":"https://stock-news.laohu8.com/highlight/detail?id=2541282440","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2541282440?lang=zh_cn&edition=full","pubTime":"2025-06-05 17:09","pubTimestamp":1749114597,"startTime":"0","endTime":"0","summary":"数据统计显示,中证上海现代产业发展主题指数近一个月下跌1.25%,近三个月下跌6.14%,年至今上涨4.28%。从中证上海现代产业发展主题指数持仓的市场板块来看,上海证券交易所占比87.74%、深圳证券交易所占比12.26%。从中证上海现代产业发展主题指数持仓样本的行业来看,信息技术占比53.34%、医药卫生占比17.57%、可选消费占比13.21%、通信服务占比8.09%、工业占比3.19%、主要消费占比2.44%、原材料占比2.15%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/06/05170950877144.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0196","BK0046","BK0239","BK0028","BK0188","002252"],"gpt_icon":0},{"id":"2539283337","title":"上海莱士:目前,公司暂未有相关计划;若有相关事项,公司将按照信息披露相关规则履行披露义务","url":"https://stock-news.laohu8.com/highlight/detail?id=2539283337","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2539283337?lang=zh_cn&edition=full","pubTime":"2025-05-29 08:43","pubTimestamp":1748479394,"startTime":"0","endTime":"0","summary":"证券之星消息,上海莱士(002252)05月28日在投资者关系平台上答复投资者关心的问题。投资者提问:请问,中科曙光已经实现与科创版的重组整合,上海莱士什么时候进行上海莱士回复:您好!感谢您对我公司的关心和支持! 目前,公司暂未有相关计划;若有相关事项,公司将按照信息披露相关规则履行披露义务。谢谢。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025052900005072.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0196","BK0188","BK0028","002252","BK0239"],"gpt_icon":0},{"id":"2539283368","title":"上海莱士:公司高管薪酬方案由董事会薪酬与考核委员会制定","url":"https://stock-news.laohu8.com/highlight/detail?id=2539283368","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2539283368?lang=zh_cn&edition=full","pubTime":"2025-05-29 08:40","pubTimestamp":1748479229,"startTime":"0","endTime":"0","summary":"证券之星消息,上海莱士05月28日在投资者关系平台上答复投资者关心的问题。上海莱士的高管层的薪酬是如何构成和决策的,横向比较是否合理?与分红收益率是否挂钩?谢谢上海莱士回复:您好!公司管理层团队拥有深厚的行业及专业背景,其中部分人员具有海外教育及研究背景,公司高管薪酬方案由公司董事会薪酬与考核委员会结合高管年度履职情况及目标责任完成情况等制定,公司薪酬制度符合公司发展需要。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025052900005021.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002252","BK0239","BK0046","BK0196","BK0188","BK0028"],"gpt_icon":0},{"id":"2537692195","title":"每周股票复盘:上海莱士(002252)股东户数减少,控股股东计划增持25000万至50000万","url":"https://stock-news.laohu8.com/highlight/detail?id=2537692195","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537692195?lang=zh_cn&edition=full","pubTime":"2025-05-24 19:13","pubTimestamp":1748085194,"startTime":"0","endTime":"0","summary":"截至2025年5月23日收盘,上海莱士报收于6.8元,较上周的6.76元上涨0.59%。本周,上海莱士5月22日盘中最高价报6.93元。本周关注点股本股东变化:截至2025年5月20日公司股东户数为10.54万户,较5月9日减少686.0户公司公告汇总:控股股东计划自公告披露之日起6个月内增持股份,总金额不低于人民币25,000万元,且不超过人民币50,000万元股本股东变化近日上海莱士披露,截至2025年5月20日公司股东户数为10.54万户,较5月9日减少686.0户,减幅为0.65%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025052400013455.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0196","BK0046","BK0239","002252","BK0188"],"gpt_icon":0},{"id":"2537311821","title":"上海莱士:上市公司股价受市场、政策等多重因素影响","url":"https://stock-news.laohu8.com/highlight/detail?id=2537311821","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537311821?lang=zh_cn&edition=full","pubTime":"2025-05-23 20:57","pubTimestamp":1748005039,"startTime":"0","endTime":"0","summary":"证券之星消息,上海莱士05月23日在投资者关系平台上答复投资者关心的问题。上市公司股价受市场、政策等多重因素影响。前述两次增持计划完成后,海盈康持有上海莱士1,474,578,052 股股份,占公司总股本的22.21%,并通过接受基立福所持上海莱士股份表决权委托的方式支配上海莱士437,069,656股股份,占公司总股本的6.58%对应的表决权,海盈康合计控制上海莱士1,911,647,708股股份,占公司总股本的28.80%所对应的表决权。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025052300039243.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0196","BK0028","BK0046","BK0188","BK0239","002252"],"gpt_icon":0},{"id":"2537118181","title":"上海莱士(002252)5月20日股东户数10.54万户,较上期减少0.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2537118181","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537118181?lang=zh_cn&edition=full","pubTime":"2025-05-23 17:14","pubTimestamp":1747991684,"startTime":"0","endTime":"0","summary":"证券之星消息,近日上海莱士披露,截至2025年5月20日公司股东户数为10.54万户,较5月9日减少686.0户,减幅为0.65%。在生物制品行业个股中,上海莱士股东户数高于行业平均水平,截至5月20日,生物制品行业平均股东户数为3.39万户。从股价来看,2025年5月9日至2025年5月20日,上海莱士区间涨幅为0.59%,在此期间股东户数减少686.0户,减幅为0.65%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025052300026393.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0196","BK0188","BK0239","002252","BK0046"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1752282538283,"stockEarnings":[{"period":"1week","weight":0.0102},{"period":"1month","weight":-0.0029},{"period":"3month","weight":0.0073},{"period":"6month","weight":0.039},{"period":"1year","weight":-0.1014},{"period":"ytd","weight":-0.0416}],"compareEarnings":[{"period":"1week","weight":0.0109},{"period":"1month","weight":0.0317},{"period":"3month","weight":0.084},{"period":"6month","weight":0.1078},{"period":"1year","weight":0.1817},{"period":"ytd","weight":0.0473}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"上海莱士血液制品股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"100031人(较上一季度减少1.43%)","perCapita":"66324股","listingDate":"2008-06-23","address":"上海市奉贤区望园路2009号","registeredCapital":"663798万元","survey":" 上海莱士血液制品股份有限公司的主营业务是血液制品的生产和销售。公司的主要产品是自产白蛋白、进口白蛋白、静丙、其他血液制品、检测设备及试剂。公司是“上海市外商投资先进技术企业”、“高新技术企业”。","listedPrice":12.81},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"上海莱士(002252)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供上海莱士(002252)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"上海莱士,002252,上海莱士股票,上海莱士股票老虎,上海莱士股票老虎国际,上海莱士行情,上海莱士股票行情,上海莱士股价,上海莱士股市,上海莱士股票价格,上海莱士股票交易,上海莱士股票购买,上海莱士股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"上海莱士(002252)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供上海莱士(002252)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}